HLH (Hemophagocytic Lymphohistiocytosis) At a Tertiary Care Hospital, B J Wadia Hospital for Children,In Mumbai, India

Blood ◽  
2011 ◽  
Vol 118 (21) ◽  
pp. 4936-4936
Author(s):  
Mukesh Manharlal Desai ◽  
Harvinder Iqbal Palaha ◽  
Snehal Desai ◽  
Manisha Madkaikar ◽  
Bharat Agarwal ◽  
...  

Abstract Abstract 4936 We present a retrospective analysis of HLH diagnosed at B J Wadia Hospital for Children, a tertiary care exclusive pediatric institute in Mumbai. In all, 43 cases were diagnosed as HLH as per 2009 Guidelines (Filipovich et al). There were 15 (34.9%) males and 28 (63.1%) females. The mean age was 3 yrs 4 mths with a range of 15 days to 12 yrs. The commonest presenting symptom was fever in 85% of cases. RS, GI, Renal and CNS symptoms were seen in 48.8%, 65%, 11.6% and 24% of our cases. Skin pigmentation, Petachiae, Oedma and arthritis was present in 12(27.9%); 4(9.3%), 13(30.2%), and 4(9.3%) of cases respectively. 41(95.3%) babies had Hepatomegaly while 35(81.3%) had Splenomegaly. Lymphadenopathy was seen in 13(30.2%). 12 (27.9%) had pigmentation, 13(30.2%0 had oedema while 4 (9.3%) each had petachiae and arthritis. Mean Hb of 8.2 gm/dl and a range of 3.5 to 10 gm/dl. The Mean WBC count & ANC were 8030 (range 1300 – 29400) & 4614 (300-19400). 37(86%) had thrombocytopenia. Liver injury 27(62.7%), hyponatremia 28(65.1%) and renal failure in 6(13.95%) was seen at diagnosis. Coagulopathy was present in 38(88.4%) and serum ferritin was >500 in 36(83.7%) with a mean of 26135 ng/ml and range of 82 to 200,000 ng/ml. 24(55.8) cases had Hypertriglyceridemia with mean levels of 236. 13 patients had infections 6 UTI & 7 bacterial diarrhoea. Only 2 out of 16 children had CSF abnormality at diagnosis. BM was hypo cellular in 3 and hyper cellular in 40 and all showed hemophagocytosis. PS showed HLH in 4 cases. Cultures isolated K pneumoniae in 5, P aeruginosa in 2, S. Typhi in 1, Candida in 4, and H1N1 in 1. Kalazar was the cause of HLH in 1 and 2 patients had P vivax seen on PS. 1 child had SPTCL & HLH while another child has ALCl & HLH. The child with SPTCL had gross hemophagocytosis on skin biopsy as well as in the Bone Marrow. Perforin was done in 30(70%) and was low in 6/30 (20%) cases, while GRA (Granule Release Assay) was done in 15(35%) and was abnormal in 4/15(26.6%). GRA was established last year only. In 29(67.4%) cases IAHS was diagnosed. The IAHS were, HIV 1, Post Chicken pox 1, Dengue 2, Viral aseptic meningitis 1, P vivax 1, Leishmaniasis 1, MTB in 1, S. typhi in 1, gram −ve sepsis in 8, candidia in 3, viral infection 9. 2 cases had MAS (Macrophage Activation Syndrome) with JRA; serum ferritin was as high as 200,000 ng/ml at diagnosis. 1 child had Griscelli Syndrome with HLH. Perforin deficiency presented at a mean age of 5 mths & all had severe fulminant presentation with brief H/o of viral infection and hepatosplenomegaly. Hepatic injury was severe and rapidly progressive, CNS affection was present in 3/6 cases and all died. 2/4 children with GRA abnormalities presented early at 15 days & 1 mth of life, 1 had a gm −ve sepsis with response to HLH protocol but relapsed & Died, the other child presented with fever, hepatosplenomegaly, pancytopenia & neuroregression and BMA confirmed HLH. Of the other 2 babies with GRA abnormalities 1 was a case of Griscelli who presented at 4 yrs 6 mths of life while the other presented at 1 6 mths yr of life as what appeared like IAHS and sucumbed to his disease. 2/4 with GRA abnormalities are alive and well. 1 child had thrombocytopenia and Malena as the sole presentation of HLH and the Bone Marrow done 4 times showed gross hemophagocytosis. 2/4 children with elevated creatinine required peritoneal dialysis. All our cases received Dexa, CsA & Etoposide as in HLH 2004 protocol. We ensured that the 1st 2 doses of etoposide were given after which etoposide may be witheld depending on clinical situation. IT MTX was given when there was CSf abnormalities or gross CNS signs. The Mortality was 32.5% (14/43). 3 of them died during Follow up with relapse of HLH, 1 child with ALCL died of Lymphoma while child with SPTCL is alive but with systemic symptoms. 8/43 (18.6%) are lost to follow up. Majority of IAHS did well with treatment. 8 are presently on regular follow up. In IAHS reassesment of HLH status if normal at 8 weeks, treatment was discontinued. 21/43 children completed 8 weeks of treatment. Conclusions: HLH is not an uncommon diagnosis in tertiary care centre in India. IAHS was the commonest cause of HLH and prompt dignosis with treatment HLH 2004 protocol is necessary to control the hyperinflammation. Our Ferritin values were very high. Incidence of Perforin deficiency was 20% and 26.6% respectively. Mortality in perforin deficiency was 100%. Bacterial infection and fungal infections were also common among the IAHS. Disclosures: No relevant conflicts of interest to declare.

Author(s):  
Gargi Dey ◽  
Jyothi R. ◽  
Girish K.

Background: Stroke has a high economic impact on the society especially in a developing country like India. In India health insurance doesn’t cover all people leading to out of pocket expenditure. The objective of the present study was to study the cost of illness and outcome of stroke in a tertiary care hospital.Methods: Direct medical and nonmedical costs were obtained after 28 days of follow-up. The outcome of the stroke was measured by modified Rankin scale (mRS).Results: The mean age of the patients was 65.38±13.98 years. Majority of the patients suffered from ischemic stroke and belonged to lower middle socioeconomic group. The mean cost of stroke was INR 39819. There was improvement in the mRS score after 28 days following treatment of acute stroke.Conclusions:Direct medical costs forms major component of cost of stroke. Early management and hospital discharge can reduce the economic burden of stroke. 


Blood ◽  
2010 ◽  
Vol 116 (21) ◽  
pp. 2575-2575
Author(s):  
Vipra Sharma ◽  
Maya Shah ◽  
Ravi Pullela ◽  
Alice J. Cohen

Abstract Abstract 2575 Background: Use of platelet (plt) transfusions to treat and prevent bleeding varies widely between hospitals and by medical and surgical services. Standard indications include active bleeding with thrombocytopenia or plt dysfunction, pre or peri-invasive procedure, and prophylaxis for low plt counts. Rising demand for plt transfusions and donor shortage, coupled with the risks of transfusion (including infectious disease transmission and alloimmunization) are concerns which often lead to strict regulation of plt transfusion in hospitals. In order to evaluate appropriate use of plt transfusion based on Newark Beth Israel Medical Center transfusion guidelines, a review of plt use was undertaken at this tertiary care hospital. Design: A retrospective review was performed of plt utilization over a 3 month period from October to December 2009. All charts of hospitalized and outpatient patients receiving plt transfusions were reviewed to determine reasons for plt transfusion. Pre-transfusion plt values, site/service ordering plt transfusions, number of units transfused and cost were determined. Results: 421 plt units were transfused to 125 patients (51.6% female), mean age 44 years (yrs.) (range 0–89). All plt transfusions were single donor units. The mean plt count prior to transfusion for all procedures was 127,000, well above hospital guidelines. The majority of plt utilized were by cardiothoracic (CT) surgery (168/421, 40%) with the highest cost (Table 1). 124/421(29%) of transfusions occurred pre- or peri- invasive procedure, with 88/124 (71%) of those transfusions occurring prior or peri- cardio-thoracic procedure. 83/421 (20%) of transfusions had no clear indication based on hospital guidelines, predominately ordered by CT surgery and occurring post-op for asymptomatic thrombocytopenia (cost $45, 650). The mean plt count at which transfusion was found to have no indication was 55,000 (range 25,000–105,000). 136/421(32%) of the cases were prophylactic transfusions with a plt count < 20,000, with 121/136 (89%) in the oncology patients, and the rest in the medical pts due to sepsis. 114/421(27%) of the transfusions were for bleeding. Only 5 patients, 3 in the CT group, and 2 in neonate group had plt dysfunction as the indication for transfusion prior to procedure. The lowest incidence of plt transfusions without an indication was in the adult oncology department. Conclusion: Platelet utilization varied by departments. CT surgery followed by neonatal and pediatric oncology are the principal users of plt in our tertiary care medical center. CT surgery, general surgery, and neonatal services had the highest pre-transfusion plt counts. As 20% of all transfusions had no clinical reason for plt use (no bleeding, invasive procedure, or severely low plt count) the opportunities may exist for lower platelet usage by educating physicians about compliance to transfusion guidelines in order to decrease the risks associated with transfusion and resultant complications. Disclosure: No relevant conflicts of interest to declare.


2019 ◽  
Vol 6 (6) ◽  
pp. 2287
Author(s):  
Diksha Suri ◽  
Krithika A. P. ◽  
R. Somasekar

Background: Phototherapy is safe and effective in neonatal hyperbilirubinemia. Despite its worldwide application, questions regarding methods of optimizing efficacy remain unanswered, turning the infant is believed to be one of the methods to improve. Severe neonatal hyperbilirubinemia is associated with kernicterus, condition characterized by athetoid spasticity, gaze and visual abnormalities, and sensory-neural hearing loss. It may also be associated with mental retardation. Aim of this study was conducted to compare the efficacy of intermittent with continuous phototherapy.Methods: Study was conducted in 100 neonates from February 2018 to July 2018 in Sree Balaji medical college and hospital. Inclusion criteria were weight >2000 grams, absence of other concomitant diseases, and hyperbilirubinemia not requiring exchange transfusion. The neonates were randomly divided into two groups. Continuous phototherapy group received phototherapy on and off for 2 hours and half an hour respectively and the intermittent phototherapy group on and then off for one hour. Serum total bilirubin levels were measured in every 36 hours.Results: Mean age of the patients was 3.89±1.83(p=.91) days, mean baseline bilirubin was 17.56mg/dl±1.42 (p=0.36), while the mean follow-up bilirubin was 12.85mg/dl±1.65 (p=.95), and the mean difference between the baseline and follow-up bilirubin was 4.7 mg/dl±1.19 (p=.32). For group A and B babies, the mean difference between the baseline and follow-up bilirubin was 4.78 mg/dl±1.20 (p=.32) and 4.63mg/dl±1.18(p=0.32) respectively. The difference between the mean age, mean baseline bilirubin, mean follow-up bilirubin, and the mean decrease in bilirubin for both the groups was statistically not significant.Conclusions: Intermittent and continuous phototherapies were found to be equally effective for reducing neonatal hyperbilirubinemia.


2013 ◽  
Vol 7 (3-4) ◽  
pp. E168-170 ◽  
Author(s):  
Amit Attam ◽  
Arun Kerketta ◽  
Bharat Behera ◽  
Navin Ram ◽  
Sameer Trivedi ◽  
...  

Introduction: Penile fracture may be associated with urethral trauma in 1% to 38% of cases. We present our experience in treating 8 such cases.Methods: Data were collected retrospectively from hospital records and from out-patient department follow-up visits.Results: The mean age of the patients was 30.4 years; trauma during coitus was the most common cause of the penile fracture. One patient presented after 7 days. Two patients had normal examination of their penis despite typical history. All fractures were repaired on an emergency basis via subcoronal incision. In 2 patients with normal findings, the urethra had to be mobilized to locate the site of the injury. In 1 patient, the site of the urethral trauma was 1 cm away from the site of the corporal injury, which was localized by injecting sterile methylene blue per urethra. Postoperatively, all patients voided with good flow and had erections with adequate rigidity.Conclusion: A high level of suspicion for urethral injury during surgical exploration is warranted, especially in the presence of suggestive history and examination.


Blood ◽  
2018 ◽  
Vol 132 (Supplement 1) ◽  
pp. 5355-5355
Author(s):  
Reyad Dada ◽  
Bassim T. Malas Al-Beirouti ◽  
Yazeed Zabai

Abstract Objectives : One of the newly discovered mechanisms to escape the immune response in classic Hodgkin lymphoma (cHL) is to induce immune tolerance through interaction of program cell death 1 (PD-1) on activated T cells and PD ligand-1 (PD-L1) on tumor cells. Tissue of patients with cHL was recently found to overexpress PD-L1. Nivolumab is a novel checkpoint inhibitor designed to block PD-1 and inhibits interaction between PD-1 and PD-L1. Unlike many available antibodies and chemotherapies, nivolumab itself is not cytotoxic but rather inhibits the tolerance of tumor cells through activation of the immune system. Patients and methods: We report on ten patients with relapsed/refractory cHL who were treated between 05/2016 and 03/2018 with single agent nivolumab in a tertiary care hospital. Follow-up was performed after 4 cycles with positron emission tomography (PET). Patients' files were retrospectively analyzed. Results: Mean age was 26.2 year (range 15-40). Prior to nivolumab 3/10 and 5/10 patients failed ASCT and brentuximab vedotin respectively. Mean follow-up time was 12.3 months (range 5-32). Average of prior lines was 6.3. After 4 cycles of nivolumab response rate was 80% with complete metabolic (CR) and partial remission rates of 70% and 10% respectively. In one case PET showed stable disease and another patient experienced progressive disease. Three deaths occurred after 5, 9 and 32 months of nivolumab's initiation. One patients experienced pneumonitis grade 2 which was manageable by oral steroids. Another patient had an asymptomatic TSH elevation. Two patients had grade 2 neutropenia. No serious adverse events (grade ≥3) were observed. All patients experienced a remarkable improvement of quality of life. On treatment start, two patients had performance status ECOG 3 and 4 which were attributed to refractory Hodgkin lymphoma. They recovered dramatically each to ECOG 2 within 7 days and 10 days after nivolumab start respectively. Conclusion: The CR rate seen in our cohort supports the high sensitivity of relapsed/refractory cHL to checkpoint inhibition seen in Checkmate 205. Nivolumab induces impressive clinical and radiological responses with excellent tolerance. The drug enriches our treatments armamentarium in treating cHL. Further controlled studies are needed to determine the effectiveness on a large patients' cohort and its role in earlier lines. Disclosures No relevant conflicts of interest to declare.


Blood ◽  
2014 ◽  
Vol 124 (21) ◽  
pp. 2615-2615
Author(s):  
Uday Yanamandra ◽  
Kamal Kant Sahu ◽  
Nidhi Jain ◽  
Shano Naseem ◽  
Alka Khadwal ◽  
...  

Abstract Introduction: The clinical behaviour and disease prognosis of AYA-CML is much different from adult CML. The outcome of this group of patients in resource constraints setting is not known where patients are seen in late chronic phase. Objectives: To study the survival pattern of AYA-CML in resource constraint settings. Methodology: It is a retrospective observational study wherein the data of all patients of AYA-CML managed at tertiary care centre in North India over last 14 years were analysed. All case records of the AYA-CML were perused, digitalised and their survival statistics derived. Results: Amongst a total of 1815 CML case records, 431 (23.74%) were AYA-CML. AYA-CML cases with complete data (n-225) were analysed for overall survival. The mean age of the patients was 23.08 ± 4.325 years (range 12-29). Males constituted 60.9% (n-137) and females, 39.1% (n-88) of AYA-CML. Of these 117 (52%) were single and 108 (48%) were married. Sixty one percentage of patients were educated upto 10th grade and 22.7% upto 5th grade and 8% received no formal education. Only 22.7% were educated beyond 12th grade. The mean monthly income was $75 (range $5-493). Ninety four percentage of patients had at least 12 months of follow up and 85.3% patients had at least 24 months of follow-up. The median delay in CML diagnosis from symptom onset was 62 days (range 0-2568). The details of therapy and complete haematological remission achieved in patients are described in table 1. The cumulative overall survival (OS) was 84% with no statistical difference in males and females (83.2%, 85.2% respectively) (Fig 1A, B). Survival rate at 1, 3, 5 and 8 years was 94.2%, 86.5% 78% and 74.2% respectively. Median OS was 1034 days (range 0-4788). OS was significantly better in patients receiving free drugs under Novartis Oncology Access (NOA) Program (p<0.001) (Fig 1C). OS was also better in the patients who received Imatinib within 3 months of symptom onset (Fig 1D). The OS in different risk categories of Sokal, Hasford and EUTOS, however, was not different. (Fig 2A-C). On Cox regression analysis there was no significant effect of age or sex on overall survival. The OS was positively correlated to age (r- 0.104, p 0.118) and negatively correlated with the time taken to diagnosis from symptom onset (r - 0.08, p 0.229). Conclusion: We have demonstrated in this study the improved outcomes of AYA-CML who usually present in late chronic phase in resource constraint settings. Prognostic scoring has no significant correlation to the OS in our study population. The delay in diagnosis from symptom onset had a negative correlation to OS and starting Imatinib within 3 months of symptom onset had a positive effect on OS, both of these can be addressed by improving patient as well as general physician's education. Patients on free medication through NOA had a better OS than the other group, suggesting increased efforts to register more patients in NOA through community based education programmes. Table 1:Therapy details and CHR characteristics in AYA CMLNMinimumMaximumMeanStd. DeviationDuration for which patient was on Hydroxyurea (months)213072.005.9711.74Time gap in starting Imatinib from date of diagnosis (days)21402158181.66339.81Time gap in starting Imatinib from symptom onset (days)21402652339.73431.91Duration for achieving CHR post symptom onset (days)20202694377.82464.95Duration for achieving CHR post Imatinib (days)201-5251324107.40194.98Duration for CHR achievement post diagnosis (days)20202455232.80329.55Overall Survival (days)225047881391.881119.62Duration of Imatinib Therapy (days)214041281276.361083.53 Figure 1 Figure 1. Figure 2 Figure 2. Disclosures No relevant conflicts of interest to declare.


Blood ◽  
2020 ◽  
Vol 136 (Supplement 1) ◽  
pp. 33-34
Author(s):  
Ruth Namazzi ◽  
Robert Opoka ◽  
Andrea L Conroy ◽  
Dibyadyuti Datta ◽  
Micheal Goings ◽  
...  

COVID-19 and its prevention has put considerable strain on health care systems in low and middle-income countries (LMIC). In Uganda, a national lockdown was declared on March 18, 2020, in response to COVID-19 pandemic and concern of spread of cases without aggressive measures to prevent spread. The lockdown consisted of closure of all offices except essential ones, orders to stay at home unless an emergency occurred, school closure, a ban on all meetings of more than 10 people, a ban on public and private transport, closing down of all shops, malls, restaurants, places of worship and other facilities in which group meetings might occur, keeping a distance of at least 2 metres from other people in public places and a 7:00 p.m. to 6:30 a.m. curfew. Hospitals however remained open and operational. We describe the impact of the lockdown in Uganda in response to the COVID-19 pandemic on the morbidity and mortality in children with sickle cell anaemia (SCA) at a tertiary hospital in Uganda. The number of clinic visits for SCA related complications and death were compared in the pre-lockdown (November 2019 to February 2020) and during COVID-19 lockdown periods (March 2020 to June 2020) in children aged 1- 4.99 years enrolled in a SCA research study [Zinc for Infection Prevention in Sickle cell anaemia (NCT03528434)] at Jinja Hospital, Uganda. In the study, children with SCA are asked to return to the hospital for evaluation whenever they are unwell. Follow up phone calls are made to ascertain the wellbeing of the children and identify any who are unable to come to the hospital. During the lockdown, follow up calls continued and facilitation was provided for caregivers to bring any child who was unwell to the hospital for evaluation. A total of 238 children with a mean (standard deviation) age of 2.7(1.1) years were enrolled and were being followed up when the pandemic started. The incidence of hospital sick visits pre-lockdown and during the lockdown period was 7.7 vs 4.0 person-year, (p= &lt;0.0001). Incidence of hospitalization, pain crises, severe anaemia, or malaria were all higher in the pre-lockdown period than during the lockdown period, 2.4 vs.1.0, 1.8 vs. 0.7, 0.7 vs. 0.4, 0.6 vs. 0.2 and per person year respectively (all p values &lt; 0.01). There were no deaths during the lockdown period compared to 1 death in the pre-lockdown period. Less than 1000 cases of COVID-19 were reported nationally in this period, and none of the study children had known COVID-19 infection, though testing capacity for this was limited. In this cohort of children with SCA, hospitalization and morbidity from SCA-related complications and malaria were are significantly lower during a lockdown period for COVID-19 pandemic than before the lockdown. Reduced access to hospital care is unlikely to explain these findings, as sick children still received care at the hospital, and there was no increase in mortality. Reduced interaction with peers because of the lockdown and social distancing, leading to fewer infections that may trigger SCA-complications, may explain the reduced incidence of SCA complications in this population during the COVID-19 lockdown period in Uganda. Disclosures No relevant conflicts of interest to declare.


2015 ◽  
Vol 13 (4) ◽  
pp. 530-534 ◽  
Author(s):  
Fernando Korn Malerbi ◽  
Nilson Hideo Matsudo ◽  
Adriano Biondi Monteiro Carneiro ◽  
Claudio Luiz Lottenberg

ABSTRACT Objective To describe retinal diseases found in patients who were waiting for treatment at a tertiary care hospital in Rio Branco, Acre, Brazil. Methods Patients underwent slit lamp biomicroscopy, dilated fundus exam and ocular ultrasound. Patients were classified according to phakic status and retinal disease of the most severely affected eye. Results A total of 138 patients were examined. The mean age was 51.3 years. Diabetes was present in 35.3% and hypertension in 45.4% of these patients. Cataract was found in 23.2% of patients, in at least one eye. Retinal examination was possible in 129 patients. The main retinal diseases identified were rhegmatogenous retinal detachment (n=23; 17.8%) and diabetic retinopathy (n=32; 24.8%). Out of 40 patients evaluated due to diabetes, 13 (32.5%) had absent or mild forms of diabetic retinopathy and did not need further treatment, only observation. Conclusion Diabetic retinopathy was the main retinal disease in this population. It is an avoidable cause of blindness and can be remotely evaluated, in its initial stages, by telemedicine strategies. In remote Brazilian areas, telemedicine may be an important tool for retinal diseases diagnosis and follow-up.


2017 ◽  
Vol 4 (2) ◽  
pp. 543 ◽  
Author(s):  
Rameshwar L. Suman ◽  
Anuradha Sanadhya ◽  
Pradeep Meena ◽  
Jaskaran Singh ◽  
Rupali Jain ◽  
...  

Background: β-thalassemia major is a secondary iron load state. The high serum ferritin accounts for abnormal lipid profile. This study was done to investigate the lipid profile in children with β-thalassemia major and to know their correlation with serum ferritin.Methods: Fifty-five (55) children of beta thalassemia major in the age group of 4-20 years from thalassemia unit of tertiary care hospital who were on regular blood transfusion and oral iron chelators were enrolled. Serum ferritin levels and lipid profile of these children were investigated and their correlation was assessed. Results: Out of total 55 children 31 (56.4%) children were of female sex and 48(87.3%) were Hindu by religion. The mean rate of blood transfusion was 157.02±21.33 ml/kg/year with average dose and duration of iron chelation with Desferroxamine was 34.4±26.86 mg/kg /day and 2.34±1.86 years respectively. Mean cholesterol level, high density lipoprotein (HDL), low density lipoprotein (LDL) levels were on lower side of the range with values of 124.47±19.81 mg/dl, 36.58±12.22 mg/dl, 63.94±4.57 mg/dl respectively. The mean triglyceride level (TG) was on higher side with an average of 142.93±33.7 mg/dl. The average serum ferritin levels were 2130.33±859.85 ng/ml. There was negative correlation of total cholesterol, HDL, LDL with serum ferritin with coefficient of correlation (r= -0.77, -0.55, -0.72) respectively. The serum triglyceride had positive correlation with serum ferritin with coefficient of correlation(r=+0.85).Conclusions: As the serum ferritin increases, there occurs more derangement of lipid profile in form of decreasing serum cholesterol, HDL, LDL and increasing serum TG levels.


2017 ◽  
Vol 13 (3) ◽  
pp. 129-136
Author(s):  
Poonam Lavaju ◽  
BP Badhu ◽  
S Shah ◽  
SK Chaudhary ◽  
P Upadhyaya

Background: Retinoblastoma is the commonest primary intraocular malignancy of childhood. Under-standing the different modes of presentation with timely intervention are associated with prognosis.Objective: To determine the clinical profile of retinoblastoma and its association with optic nerve infiltration by tumor.  Methods: A retrospective analysis of the clinical records and histopathological reports of patients admitted with retinoblastoma in a tertiary heath care center, eastern Nepal (June 2009 to July 2012) was carried out.Results: A total of 27 patients (28 eyes) with retinoblastoma were studied. The mean age at presentation was 2.89 ± 0.93 years. The mean duration of symptoms to presentation was 3.35 month, ranged from 7 days to 2 years. Male to female ratio was 3:2. Thirty-three percent patients were Muslims. Twentyseven patients (96.3%) had unilateral eye involvement. The commonest mode of presentation was leukocoria in 23 eyes (85.2%) followed by redness 9 eyes (33.3%), proptosis in 5 eyes (18.5%) and phthisis bulbi in one eye (3.7%). Histopathological reports of 26 eyes confirmed the diagnosis of retinoblastoma. One patient with distant metastases was referred to oncology center. Infiltration of the optic nerve by tumor cells was seen in five eyes (18.5%); of which two cases had proptosis (p-0.166). At two years follow up, recurrence was seen in one patient with proptosis and optic nerve infiltration (p-0.136). Age at presentation was positively associated with recurrence of tumor (p-0.005).Conclusion: Leucokoria was the most common mode of presentation of retinoblastoma. Larger sample size with longer follow up is required to come to a definite association with optic nerve infiltration by tumor. Health Renaissance 2015;13 (3): 129-136


Sign in / Sign up

Export Citation Format

Share Document